APD

Air Products has a high-quality, defensible industrial-gases franchise built on long-term, take-or-pay style contracts, on-site pipeline networks, and switching costs that support stable demand across manufacturing, energy, and healthcare. Strategically, the company is leaning into decarbonization-driven growth, with NEOM positioning APD as a scaled early mover in green ammonia (targeting first product in 2027). The key debate is whether hydrogen/ammonia growth offsets cyclical industrial volumes and execution risk in mega-projects.

Recent results show solid momentum: fiscal 2026 Q2 sales were about $3.2B (up ~9% YoY) with GAAP EPS of $3.19 and GAAP operating margin of 23.7%, and management reaffirmed fiscal 2026 adjusted EPS guidance of $12.85–$13.15 plus capex around $4.0B. The balance sheet looks workable but levered for a capital-intensive model, with long-term debt about $17.1B and cash about $951M as of March 31, 2026. Valuation appears mid-to-full versus industrial peers, with a cited P/E around the low 30s and a 2.5% dividend yield, so multiple expansion likely needs visible hydrogen cash flows.

Over the next 12 months, the setup is a “steady core + optionality” story: resilient base earnings with upside if project execution and pricing hold. Catalysts include progress updates and commercial milestones toward NEOM commissioning (and any clarity on offtake economics), plus sustained delivery within the $12.85–$13.15 FY26 adjusted EPS range. Key risks are cost overruns/delays in NEOM or other large projects, and industrial demand softness that could pressure volumes and returns on capital.

Recommendation: HOLD. The shares offer dependable cash returns and improving near-term earnings, but the valuation already prices in meaningful decarbonization success while large-project execution and balance-sheet intensity remain real swing factors.